Question from Deputy Pádraig O’Sullivan - PQ 35183-26

To ask the Minister for Health if she will outline what steps her Department is taking to address the fact that brexpiprazole and lurasidone, two antipsychotic medicines now recommended as first-line treatment options for females with first-episode psychosis in the first international clinical guideline of its kind published in March 2026, are currently licensed in Ireland but not reimbursable under community drugs schemes; and if she will make a statement on the matter.